Crossref
journal-article
Elsevier BV
Immunity (78)
References
42
Referenced
301
10.4049/jimmunol.154.3.985
/ J. Immunol / Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation by Abe (1995)10.4049/jimmunol.153.9.4142
/ J. Immunol / Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis by Corry (1994)10.1172/JCI117982
/ J. Clin. Invest / Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation by Cross (1995)10.1016/0896-8411(91)90021-4
/ J. Autoimmun / Prevention of diabetes in NOD mice treated with antibody to murine IFNγ by Debray-Sachs (1991)10.2337/diab.43.12.1494
/ Diabetes / Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice by Elliott (1994)10.1126/science.7520604
/ Science / Treatment of murine lupus with CTLA-4Ig by Finck (1994)10.1016/1074-7613(94)90092-2
/ Immunity / Absence of B7-dependent responses in CD28-deficient mice by Green (1994)10.1038/356607a0
/ Nature / CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T cell clones by Harding (1992)10.1016/0167-5699(94)90080-9
/ Immunol. Today / The B7 and CD28 receptor families by June (1994)10.1016/0092-8674(93)90730-E
/ Cell / Following a diabetogenic T cell from genesis through pathogenesis by Katz (1993)10.1126/science.7761837
/ Science / T helper cell subsets in insulin-dependent diabetes by Katz (1995)10.1038/366069a0
/ Nature / Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes by Kaufman (1993)10.1097/00007890-199602150-00003
/ Transplantation / Skin allograft rejection in CD28-deficient mice by Kawai (1996)10.4049/jimmunol.155.3.1032
/ J. Immunol / Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4 by Kearney (1995)10.1016/0092-8674(95)90349-6
/ Cell / B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways by Kuchroo (1995)10.1084/jem.182.2.459
/ J. Exp. Med / CD28 and CTLA-4 deliver opposing signals which regulate the response of T cells to stimulation by Kummel (1995)10.1084/jem.179.3.819
/ J. Exp. Med / B cell function in mice transgenic for mCTLA-4-Hγ1 by Lane (1994)10.1084/jem.181.3.1145
/ J. Exp. Med / Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse by Lenschow (1995)10.1146/annurev.immunol.14.1.233
/ Annu. Rev. Immunol / CD28/B7 system of T cell costimulation by Lenschow (1996)10.1073/pnas.84.5.1374
/ Proc. Natl. Acad. Sci. USA / Identification of a monoclonal antibody specific for murine T3 by Leo (1987)10.4049/jimmunol.154.11.5757
/ J. Immunol / Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response by Lucas (1995)10.4049/jimmunol.152.11.5220
/ J. Immunol / Costimulator dependence of lymphokine secretion by naive and activated CD4+ T lymphocytes from TCR transgenic mice by McKnight (1994)10.1002/eji.1830251112
/ Eur. J. Immunol / Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule by Nakajima (1995)10.1002/eji.1830240602
/ Eur. J. Immunol / Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis by Nishikawa (1994)10.4049/jimmunol.154.3.1481
/ J. Immunol / Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis by Perrin (1995)10.1084/jem.178.1.87
/ J. Exp. Med / Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice by Rapoport (1993)10.1016/0022-1759(93)90104-F
/ J. Immunol. Meth / Constructing polycompetitor cDNAs for quantitative PCR by Reiner (1993)10.1084/jem.179.3.809
/ J. Exp. Med / Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo by Ronchese (1994)10.1084/jem.179.1.299
/ J. Exp. Med / CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production by Seder (1994)10.1126/science.7688139
/ Science / Differential T cell costimulatory requirements in CD28-deficient mice by Shahinian (1993)10.1006/jaut.1993.1025
/ J. Autoimmun / Altered cytokine activity in adjuvant inhibition of autoimmune diabetes by Shehadeh (1993)10.1128/jb.174.18.5820-5826.1992
/ J. Bacteriol / Escherichia coli has two homologous glutamate decarboxylase genes that map to distinct loci by Smith (1992)10.1084/jem.182.1.139
/ J. Exp. Med / CD43 is a murine T cell costimulatory receptor that functions independently of CD28 by Sperling (1995)10.1038/366072a0
/ Nature / Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice by Tisch (1993)10.1016/1074-7613(95)90125-6
/ Immunity / Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4 by Tivol (1995)10.1084/jem.181.2.817
/ J. Exp. Med / Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice by Trembleau (1995)10.1002/eji.1830230102
/ Eur. J. Immunol / Development of human Th1 and Th2 cytokine responses by van der Pouw-Kraan (1993)10.1101/gad.5.5.714
/ Genes Dev / Transgenic mice provide new insights into the role of TGF−α during epidermal development and differentiation by Vassar (1991)10.1016/1074-7613(94)90071-X
/ Immunity / CTLA-4 can function as a negative regulator of T cell activation by Walunas (1994)10.1126/science.270.5238.985
/ Science / Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4 by Waterhouse (1995)10.1182/blood.V86.9.3479.bloodjournal8693479
/ Blood / Critical role of CD28/B7 co-stimulation in the development of human Th2 cells by Webb (1995)10.1146/annurev.iy.13.040195.001143
/ Annu. Rev. Immunol / Genetic control of autoimmune diabetes in the NOD mouse by Wicker (1995)
Dates
Type | When |
---|---|
Created | 21 years, 3 months ago (May 1, 2004, 5:50 a.m.) |
Deposited | 2 years, 4 months ago (April 28, 2023, 10:35 a.m.) |
Indexed | 15 hours, 31 minutes ago (Aug. 31, 2025, 6:03 a.m.) |
Issued | 28 years, 11 months ago (Sept. 1, 1996) |
Published | 28 years, 11 months ago (Sept. 1, 1996) |
Published Print | 28 years, 11 months ago (Sept. 1, 1996) |
@article{Lenschow_1996, title={CD28/B7 Regulation of Th1 and Th2 Subsets in the Development of Autoimmune Diabetes}, volume={5}, ISSN={1074-7613}, url={http://dx.doi.org/10.1016/s1074-7613(00)80323-4}, DOI={10.1016/s1074-7613(00)80323-4}, number={3}, journal={Immunity}, publisher={Elsevier BV}, author={Lenschow, Deborah J and Herold, Kevan C and Rhee, Lesley and Patel, Bina and Koons, Ann and Qin, Hui-Yu and Fuchs, Elaine and Singh, Bhagarith and Thompson, Craig B and Bluestone, Jeffrey A}, year={1996}, month=sep, pages={285–293} }